ALBO
Albireo Pharma, Inc. Common Stock
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
42 hedge funds and large institutions have $19.3M invested in Albireo Pharma, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 9 closing their positions.
Holders
42
Holders Change
–
Holders Change %
0%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
9
Reduced
11
Closed
9
Calls
$870K
Puts
$258K
Net Calls
+$612K
Net Calls Change
-$1.18M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$1.49M |
| 2 |
FNYS
2
First New York Securities
New York
|
$1.64M |
| 3 |
VAM
3
Visium Asset Management
New York
|
$436K |
| 4 |
4
Renaissance Technologies
New York
|
$332K |
| 5 |
5
Two Sigma Investments
New York
|
$231K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $0 | 2 | -12 | -86% |
|
52
Barclays
London,
United Kingdom
| – | – | – | – |
|
|
VKH
53
Virtu KCG Holdings
New York
| – | – | – | – |
|